# To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.

> **NCT05287100** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 35 (actual)

## Conditions studied

- Cirrhosis, Liver

## Interventions

- **DRUG:** Midodrine Oral Tablet
- **OTHER:** Standard Medical Treatment

## Key facts

- **NCT ID:** NCT05287100
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2023-05-30
- **Final completion:** 2023-05-30
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05287100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05287100, "To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05287100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*